Clearbridge Expands Laboratory Testing Services in Indonesia

Aug 23, 2018

|

NEW YORK (360Dx) – Clearbridge Health today announced a non-binding memorandum of understanding between its wholly owned SAM Laboratory subsidiary and two Indonesian health companies to provide diagnostics services to multiple Indonesian public hospitals.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Breaking News

Dec

02

Featured Webinar

Comprehensive Profiling of Myeloid Malignancies with Reliable Detection of   FLT3  and  CEBPA

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

Dec

05

Featured Webinar

Improving the Diagnosis of Infectious Diseases with Microbial Genomic Analysis

The discovery of microbial cell-free DNA has propelled the introduction of new technologies that can be leveraged for next-generation diagnostic assays. Previously inaccessible genomic information can now be comprehensively surveyed for microorganisms, all from a single blood draw.

Dec

10

Featured Webinar

Maximizing Diagnostic Yield with an Optimized Variant Interpretation Platform

This webinar will discuss the use of next-generation sequencing and an optimized variant interpretation workflow to increase diagnostic yield in complex clinical cases.

Menu

Clearbridge Expands Laboratory Testing Services in Indonesia

To read the full story....

Breaking News

BD Tells Shareholders to Reject Unsolicited Mini-Tender Offer

Qiagen Says It Is Fielding Acquisition Offers

HTG Molecular Diagnostics Files for $20M Stock Offering

Opko 4Kscore Prostate Cancer Test Receives LCD

OncoCyte Q3 Net Loss Up 73 Percent

In Brief This Week: PerkinElmer, Invitae, Quotient Limited, and More

Comprehensive Profiling of Myeloid Malignancies with Reliable Detection of   FLT3  and  CEBPA

Improving the Diagnosis of Infectious Diseases with Microbial Genomic Analysis

Maximizing Diagnostic Yield with an Optimized Variant Interpretation Platform

What's Popular?

AMP Attendees Reflect on Uptake of Tumor Mutational Burden Amid Validation, Utility Questions

Opko 4Kscore Prostate Cancer Test Receives LCD

ACMG, ClinGen Publish Recommendations for Interpretation, Reporting of CNVs

Outreach Lab Acquisitions Slow to Develop Despite Continued Pricing Pressures

Anthem Remains Committed to Rate-Alignment Policy One Year In

Sponsorships